Universidade do Estado do, Rio de Janeiro, Brazil.
Asian Pac J Cancer Prev. 2024 Nov 1;25(11):3755-3759. doi: 10.31557/APJCP.2024.25.11.3755.
Human papillomavirus (HPV) causes almost all cases of cervical cancer and its prevalence can be significantly reduced by vaccines. This study aimed to compare the prevalence of preneoplastic and neoplastic uterine cervix lesions in the cytology of Brazilian women aged 20-24 yr before and after the HPV vaccination campaign. The study also correlates these findings with the proportional coverage of first and second doses for this population.
An ecological study was conducted and data from DATASUS were analyzed from 2020 to 2024. Data were collected from women aged 20-24 yr who had oncotic pap smears between 2020 and 2024, and the prevalence ratios (PRs) were calculated in relation to 2020.
Following the vaccination program, the prevalence rate of tests with HPV-induced lesions in Brazil and the north, southeast, and south regions decreased by 0.85, 0.75, and 0.83, respectively, in 2023. No significant reductions were observed in the northeast and central-west regions.
Although the second dose had reduced coverage, HPV-induced lesions were observed to decrease in Brazil and the north, southeast, and south after 10 yr of the beginning of the vaccination program. Decrease in HPV-induced lesions over time after vaccination did not follow similar trend in the northeast or central-west regions as in other parts.
人乳头瘤病毒(HPV)几乎可引起所有宫颈癌病例,而疫苗的接种可显著降低 HPV 的流行率。本研究旨在比较巴西 20-24 岁女性接种 HPV 疫苗前后细胞学检查中子宫颈癌前病变和肿瘤的流行率,并将这些发现与该人群首针和第二针的比例覆盖率相关联。
进行了一项生态学研究,对 2020 年至 2024 年 DATASUS 的数据进行了分析。研究对象为 2020 年至 2024 年间接受过巴氏涂片检查的 20-24 岁女性,计算了与 2020 年相比的流行率比(PR)。
疫苗接种计划实施后,2023 年巴西及北部、东南部和南部地区 HPV 引起的病变检测阳性率分别下降了 0.85、0.75 和 0.83;东北部和中西部地区则未见显著下降。
尽管第二针的覆盖率有所降低,但在疫苗接种计划开始后的 10 年内,巴西及北部、东南部和南部地区 HPV 引起的病变数量有所减少。接种疫苗后 HPV 引起的病变数量随时间减少的趋势在东北部或中西部地区与其他地区不同。